Blog Search

Vital Options International Presents Two Programs During The Asco Cancer Conference Working To Improve Patients’ Access To The Latest Cancer Treatments

Vital Options International will present two programs to ensure that the medical advances being discussed at ASCO are made available to treat the patients who need them. ASCO 2015 in Chicago, the annual meeting of the American Society of Clinical Oncology…
VITAL OPTIONS INTERNATIONAL PRESENTS TWO PROGRAMS DURING THE ASCO CANCER CONFERENCE WORKING TO IMPROVE PATIENTS’ ACCESS TO THE LATEST CANCER TREATMENTS Accelerating Innovation: L… http://mylifeisworthit.org/blog/2015/05/vital-options-international-presents-two-programs-during-asco-cancer-conference-working-improve-patients-access-latest-cancer-tr/

Will Insurers Discriminate Against People With Cystic Fibrosis?

Cystic fibrosis patients face highest cost sharing for life saving drugs. Another new one might not even be available.
Though medicines for cystic fibrosis are life saving,  insurers and pharmacy benefit managers force people with the disease to pay thousands of dollars out of pocket for them.  No… http://mylifeisworthit.org/blog/2015/05/will-insurers-discriminate-against-people-cystic-fibrosis/

Express Scripts Goes After Kids With CY

The FDA will approve only the second targeted treatment for people with cystic fibrosis. Once again, Express Scripts complains about the cost and ignores the value.
http://mylifeisworthit.org/blog/2015/05/express-scripts-goes-after-kids-cy/

Cheaper Biotech Drugs Come to U.S. as Novartis Gets FDA Approval

(Bloomberg) -- Americans are poised to gain access to cheaper therapies for serious ailments from cancer to arthritis with approval today of the first biosimilar in the U.S., Novartis AG’s version of Amgen Inc.’s Neupogen. For years, pharmaceutical and b…
http://mylifeisworthit.org/blog/2015/05/cheaper-biotech-drugs-come-us-novartis-gets-fda-approval/